Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Hepatology (Baltimore, Md.)
|
May 1, 1991
HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B
R G Paul, S T Roodman, C R Campbell, et al.
The Journal of Infectious Diseases
|
May 1, 1984
Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students
R P Perrillo, G A Storch, C J Bodicky, et al.
Annals of Internal Medicine
|
January 1, 1984
Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis
R P Perrillo, C R Campbell, G E Sanders, et al.
Digestive Diseases and Sciences
|
November 1, 1980
Complementary use of computerized tomography and technetium scanning in the diagnosis of accessory spleen
S N Joshi, M K Wolverson, R B Cusworth, et al.
Journal of Medical Virology
|
April 1, 1989
Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy
M C Kuhns, A L McNamara, R P Perrillo, et al.
The New England Journal of Medicine
|
December 21, 1995
A preliminary trial of lamivudine for chronic hepatitis B infection
J L Dienstag, R P Perrillo, E R Schiff, et al.
JAMA
|
November 11, 1983
Prevaccination screening of medical and dental students. Should low levels of antibody to hepatitis B surface antigen preclude vaccination?
R P Perrillo, M L Parker, C Campbell, et al.
The Journal of Infectious Diseases
|
April 1, 1979
A partial characterization of hepatitis B e antigen
C R Weil, D L Hilton, W Wellinghoff, et al.
Gastroenterology
|
June 1, 1979
Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus
R P Perrillo, L Gelb, C Campbell, et al.
Gastroenterology
|
March 1, 1985
Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B
R P Perrillo, F G Regenstein, C J Bodicky, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Hepatology (Baltimore, Md.)
|
May 1, 1991
HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B
R G Paul, S T Roodman, C R Campbell, et al.
The Journal of Infectious Diseases
|
May 1, 1984
Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students
R P Perrillo, G A Storch, C J Bodicky, et al.
Annals of Internal Medicine
|
January 1, 1984
Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis
R P Perrillo, C R Campbell, G E Sanders, et al.
Digestive Diseases and Sciences
|
November 1, 1980
Complementary use of computerized tomography and technetium scanning in the diagnosis of accessory spleen
S N Joshi, M K Wolverson, R B Cusworth, et al.
Journal of Medical Virology
|
April 1, 1989
Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy
M C Kuhns, A L McNamara, R P Perrillo, et al.
The New England Journal of Medicine
|
December 21, 1995
A preliminary trial of lamivudine for chronic hepatitis B infection
J L Dienstag, R P Perrillo, E R Schiff, et al.
JAMA
|
November 11, 1983
Prevaccination screening of medical and dental students. Should low levels of antibody to hepatitis B surface antigen preclude vaccination?
R P Perrillo, M L Parker, C Campbell, et al.
The Journal of Infectious Diseases
|
April 1, 1979
A partial characterization of hepatitis B e antigen
C R Weil, D L Hilton, W Wellinghoff, et al.
Gastroenterology
|
June 1, 1979
Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus
R P Perrillo, L Gelb, C Campbell, et al.
Gastroenterology
|
March 1, 1985
Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B
R P Perrillo, F G Regenstein, C J Bodicky, et al.
Page
of 10